Product overview
Vaccine type
Respiratory Syncytical Virus vaccine
Commercial Name
Abrysvo
Manufacturer
Pfizer Europe MA EEIG
Manufacturer Country
Belgium
Responsible NRA
European Medicines Agency
Country
Netherlands
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Two vial set (active + excipient)
Number of Doses
3
Diluent
Water for Injection
Route of Administration
Intramuscular
Shelf Life
24 months
Storage Temperature
2 - 8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Active: Carton of 25 vials (75 doses). [Dimensions: 8.6 x 8.6 x 4.1 cm]. Diluent: Carton of 25 vials (doses) [Dimensions: 8.6 x 8.6 x 4.1 cm].
Tertiary Packaging
Active: Box containing 36 cartons of 25 vials (900 vials/ 2700 doses) [Dimensions: 36.2 x 27.6 x 14.7 cm]. Diluent: Box containing 36 cartons of 25 vials (900 vials/ 2700 doses) [Dimensions: 36.2 x 27.6 x 14.7 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Vaccine Preservative
none
Cold Chain Volume
4.04 cm3/dose (in secondary packaging)